These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 23819736)

  • 21. Using poisons information service data to assess the acute harms associated with novel psychoactive substances.
    Wood DM; Hill SL; Thomas SH; Dargan PI
    Drug Test Anal; 2014; 6(7-8):850-60. PubMed ID: 24832864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS.
    Wadsworth E; Drummond C; Deluca P
    Brain Sci; 2018 Mar; 8(3):. PubMed ID: 29547520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Psychoactive properties of alpha-methyltryptamine: analysis from self reports of users.
    Wilcox J
    J Psychoactive Drugs; 2012; 44(3):274-6. PubMed ID: 23061328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychoactive substances use experience and addiction or risk of addiction among by Polish adolescents living in rural and urban areas.
    Pawłowska B; Zygo M; Potembska E; Kapka-Skrzypczak L; Dreher P; Kędzierski Z
    Ann Agric Environ Med; 2014; 21(4):776-82. PubMed ID: 25528919
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia.
    Burns L; Roxburgh A; Bruno R; Van Buskirk J
    Drug Test Anal; 2014; 6(7-8):840-5. PubMed ID: 24574080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Who sells what? Country specific differences in substance availability on the Agora cryptomarket.
    Van Buskirk J; Naicker S; Roxburgh A; Bruno R; Burns L
    Int J Drug Policy; 2016 Sep; 35():16-23. PubMed ID: 27520115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of (2-aminopropyl)indole positional isomers in forensic samples.
    Scott KR; Power JD; McDermott SD; O'Brien JE; Talbot BN; Barry MG; Kavanagh PV
    Drug Test Anal; 2014; 6(7-8):598-606. PubMed ID: 23836607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of use and acute toxicity associated with the use of NBOMe drugs.
    Wood DM; Sedefov R; Cunningham A; Dargan PI
    Clin Toxicol (Phila); 2015 Feb; 53(2):85-92. PubMed ID: 25658166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The hallucinogenic world of tryptamines: an updated review.
    Araújo AM; Carvalho F; Bastos Mde L; Guedes de Pinho P; Carvalho M
    Arch Toxicol; 2015 Aug; 89(8):1151-73. PubMed ID: 25877327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDMB-CHMICA: Availability, Patterns of Use, and Toxicity Associated With This Novel Psychoactive Substance.
    Haden M; Archer JR; Dargan PI; Wood DM
    Subst Use Misuse; 2017 Jan; 52(2):223-232. PubMed ID: 27759479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.
    Helander A; Beck O; Hägerkvist R; Hultén P
    Scand J Clin Lab Invest; 2013 Aug; 73(5):400-6. PubMed ID: 23692208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of presentation and clinical toxicity after reported use of alpha methyltryptamine in the United Kingdom. A report from the UK National Poisons Information Service.
    Kamour A; James D; Spears R; Cooper G; Lupton DJ; Eddleston M; Thompson JP; Vale AJ; Thanacoody HK; Hill SL; Thomas SH
    Clin Toxicol (Phila); 2014 Mar; 52(3):192-7. PubMed ID: 24580059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interest in eight new psychoactive substances before and after scheduling.
    Ledberg A
    Drug Alcohol Depend; 2015 Jul; 152():73-8. PubMed ID: 25981311
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substances.
    Wood DM; Dargan PI
    Ther Drug Monit; 2012 Aug; 34(4):363-7. PubMed ID: 22673201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The users of Novel Psychoactive Substances: Online survey about their characteristics, attitudes and motivations.
    Soussan C; Kjellgren A
    Int J Drug Policy; 2016 Jun; 32():77-84. PubMed ID: 27184218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of qualitative research on drug use in the European Union: report on an EMCDDA project. European Monitoring Centre for Drugs and Drug Addiction.
    Fountain J; Griffiths P
    Eur Addict Res; 1999 Mar; 5(1):4-20. PubMed ID: 10085497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price.
    Brunt TM; Atkinson AM; Nefau T; Martinez M; Lahaie E; Malzcewski A; Pazitny M; Belackova V; Brandt SD
    Int J Drug Policy; 2017 Jun; 44():105-114. PubMed ID: 28472731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Psychonauts' World of Cognitive Enhancers.
    Napoletano F; Schifano F; Corkery JM; Guirguis A; Arillotta D; Zangani C; Vento A
    Front Psychiatry; 2020; 11():546796. PubMed ID: 33024436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMT (3-(2-aminopropyl)indole) and 5-IT (5-(2-aminopropyl)indole): an analytical challenge and implications for forensic analysis.
    Elliott SP; Brandt SD; Freeman S; Archer RP
    Drug Test Anal; 2013 Mar; 5(3):196-202. PubMed ID: 23042766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances.
    Guillou C; Reniero F; Lobo Vicente J; Holland M; Kolar K; Chassaigne H; Tirendi S; Schepers H
    Curr Pharm Biotechnol; 2018; 19(2):91-98. PubMed ID: 29792142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.